查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1287461

代謝組學市場：2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Metabolomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

市場概述：

全球代謝組學市場規模在2022年達到24億美元。展望未來，IMARC集團預計到2028年，市場規模將達到47億美元，在2023-2028年期間表現出11.55%的成長率（CAGR）。

代謝組學是指對細胞、生物液體、組織和生物體內的代謝物或小分子的大規模研究。此分析方法，用於在各種生物樣本和系統中進行系統的代謝分析和指紋識別。包括各種檢測技術，如核磁共振（NMR）光譜和質譜（MS），同時還有分離技術，如氣相色譜法。這些技術通常用於代謝組研究、毒理學測試和開發個性化藥物。還提供了對健康的評估和對醫療疾病（如心血管和神經系統疾病和癌症）的原因和治療的洞察。

癌症和其他慢性病發病率的增加是推動市場成長的關鍵因素之一。此外，製藥業的大幅成長，以及對個性化藥物需求的上升，也為市場成長提供了動力。代謝組學促進了對基因和蛋白質的研究，以及有助於發現和開發藥物和管理疾病進展的生物標記的發展。此外，代謝組學與機器學習（ML）的整合也有利於市場的成長。機器學習有助於準確解釋使用核磁共振和質譜技術產生的資料，並使複雜、重複和耗時的過程自動化。先進的ML軟體還提供全面的分析和可視化功能，以表示大量的資料。其他因素，包括快速城市化和生物技術領域廣泛的研究和開發（R&D）活動，預計將在未來幾年推動市場發展。

本報告中回答的關鍵問題：

  • 迄今為止，全球代謝組學市場的表現如何，未來幾年將如何表現？
  • 主要的區域市場是什麼？
  • COVID-19對全球代謝組學市場的影響是什麼？
  • 基於產品的市場細分是什麼？
  • 基於適應症的市場細分是什麼？
  • 基於應用的市場細分是什麼？
  • 該行業價值鏈的各個階段是什麼？
  • 該行業的關鍵驅動因素和挑戰是什麼？
  • 全球代謝組學市場的結構是什麼，誰是主要參與者？
  • 該行業的競爭程度如何？

目錄

第一章：前言

第二章：範圍和方法

  • 研究的目標
  • 利益相關者
  • 資料來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章：執行摘要

第四章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球代謝組學市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章：按產品分類的市場

  • 代謝組學儀器
    • 市場趨勢
    • 市場預測
  • 代謝組學生物資訊學工具和服務
    • 市場趨勢
    • 市場預測

第7章：按適應症分類的市場

  • 癌症
    • 市場趨勢
    • 市場預測
  • 心血管疾病
    • 市場趨勢
    • 市場預測
  • 神經系統疾病
    • 市場趨勢
    • 市場預測
  • 先天性代謝錯誤
    • 市場趨勢
    • 市場預測
  • 其他疾病
    • 市場趨勢
    • 市場預測

第8章：按應用分類的市場

  • 生物標記和藥物發現
    • 市場趨勢
    • 市場預測
  • 毒理學
    • 市場趨勢
    • 市場預測
  • 營養基因組學
    • 市場趨勢
    • 市場預測
  • 個體化醫療
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第九章：按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳洲
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十章：SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十一章：價值鏈分析

第十二章：波特五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：競爭格局

  • 市場結構
  • 主要競爭者
  • 主要競爭者簡介
    • Agilent Technologies Inc.
    • Biocrates Life Sciences AG
    • Bio-Rad Laboratories Inc.
    • Bruker Corporation
    • Danaher Corporation
    • Human Metabolome Technologies Inc.
    • Metabolon Inc.
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: SR1623A162_Report

Market Overview:

The global metabolomics market size reached US$ 2.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2028, exhibiting a growth rate (CAGR) of 11.55% during 2023-2028.

Metabolomics refers to the large-scale study of metabolites, or small molecules, in cells, biofluids, tissues and organisms. It is an analytical approach for systematic metabolic profiling and fingerprinting in various biological samples and systems. It consists of various detection techniques, such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS), along with separation techniques, such as gas chromatography. These techniques are commonly used for metabolome studies, toxicology testing and developing personalized medicine. They also provide an assessment of health and an insight into the causes and treatment of medical ailments, such as cardiovascular and neurological diseases and cancer.

The increasing prevalence of cancer and other chronic diseases is one of the key factors driving the growth of the market. Furthermore, a significant increase in the pharmaceutical industry, along with the rising demand for personalized medicines, is also providing a boost to the market growth. Metabolomics facilitates the study of genes and proteins, along with the development of biomarkers that aid in the discovery and development of medicines and managing disease progression. Additionally, the integration of metabolomics with machine learning (ML) is also favoring the market growth. ML aids in the accurate interpretation of data generated using the NMR and MS techniques and automates complex, repetitive and time-consuming processes. Advanced ML software also offers comprehensive analysis and visualization functions for the representation of large amounts of data. Other factors, including rapid urbanization and extensive research and development (R&D) activities in the field of biotechnology, are projected to drive the market in the upcoming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global metabolomics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, indication and application.

Breakup by Product:

  • Metabolomics Instruments
  • Metabolomics Bioinformatics Tools and Services

Breakup by Indication:

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inborn Errors of Metabolism
  • Others

Breakup by Application:

  • Biomarker and Drug Discovery
  • Toxicology
  • Nutrigenomics
  • Personalized Medicine
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, Human Metabolome Technologies Inc., Metabolon Inc., Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, etc.

Key Questions Answered in This Report:

  • How has the global metabolomics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global metabolomics market?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the indication?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global metabolomics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Metabolomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Metabolomics Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Metabolomics Bioinformatics Tools and Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cardiovascular Disorders
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Neurological Disorders
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Inborn Errors of Metabolism
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Biomarker and Drug Discovery
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Toxicology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Nutrigenomics
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Personalized Medicine
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Biocrates Life Sciences AG
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
    • 13.3.3 Bio-Rad Laboratories Inc.
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bruker Corporation
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
    • 13.3.5 Danaher Corporation
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Human Metabolome Technologies Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Metabolon Inc.
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
    • 13.3.8 Shimadzu Corporation
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Thermo Fisher Scientific Inc.
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 Financials
      • 13.3.9.4 SWOT Analysis
    • 13.3.10 Waters Corporation
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Metabolomics Market: Major Drivers and Challenges
  • Figure 2: Global: Metabolomics Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Metabolomics Market: Breakup by Product (in %), 2022
  • Figure 4: Global: Metabolomics Market: Breakup by Indication (in %), 2022
  • Figure 5: Global: Metabolomics Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Metabolomics Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Metabolomics Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: Metabolomics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Metabolomics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Metabolomics (Bioinformatics Tools and Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Metabolomics (Bioinformatics Tools and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Metabolomics (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Metabolomics (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Metabolomics (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Metabolomics (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Metabolomics (Neurological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Metabolomics (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Metabolomics (Inborn Errors of Metabolism) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Metabolomics (Inborn Errors of Metabolism) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Metabolomics (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Metabolomics (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Metabolomics (Biomarker and Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Metabolomics (Biomarker and Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Metabolomics (Toxicology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Metabolomics (Toxicology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Metabolomics (Nutrigenomics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Metabolomics (Nutrigenomics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Metabolomics (Personalized Medicine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Metabolomics (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Metabolomics (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Metabolomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: North America: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: North America: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: United States: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: United States: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Canada: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Canada: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Asia Pacific: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Asia Pacific: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: China: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: China: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Japan: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Japan: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: India: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: India: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: South Korea: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: South Korea: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Australia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Australia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Indonesia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Indonesia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Europe: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Europe: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Germany: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Germany: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: France: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: France: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: United Kingdom: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: United Kingdom: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Italy: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Italy: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Spain: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Spain: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Russia: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Russia: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Latin America: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Latin America: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Brazil: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Brazil: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Mexico: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Mexico: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Middle East and Africa: Metabolomics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Middle East and Africa: Metabolomics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Global: Metabolomics Industry: SWOT Analysis
  • Figure 81: Global: Metabolomics Industry: Value Chain Analysis
  • Figure 82: Global: Metabolomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Metabolomics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Metabolomics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Metabolomics Market Forecast: Breakup by Indication (in Million US$), 2023-2028
  • Table 4: Global: Metabolomics Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Metabolomics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Metabolomics Market: Competitive Structure
  • Table 7: Global: Metabolomics Market: Key Players